We are live on ! Find out more
EC

Enhancing Capital Portfolio holdings

AUM $135M
1-Year Est. Return 25.85%
This Fund
S&P 500
This Quarter Est. Return
+8.65%
1 Year Est. Return
+25.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$137M
AUM Growth
+$5.55M
Cap. Flow
-$3.22M
Cap. Flow %
-2.35%
Top 10 Hldgs %
41.51%
Holding
94
New
2
Increased
20
Reduced
7
Closed
7

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$697K
2
PLPC icon
Preformed Line Products
PLPC
+$327K
3
TMO icon
Thermo Fisher Scientific
TMO
+$243K
4
MA icon
Mastercard
MA
+$116K
5
AMZN icon
Amazon
AMZN
+$94.2K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.01M
2
GIS icon
General Mills
GIS
+$772K
3
APD icon
Air Products & Chemicals
APD
+$709K
4
IDR icon
Idaho Strategic Resources
IDR
+$633K
5
UNH icon
UnitedHealth
UNH
+$624K

Sector Composition

Rank Sector Weight
1 Technology 23.94%
2 Financials 14.9%
3 Utilities 11.25%
4 Industrials 10.83%
5 Healthcare 10.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRMN
26
Garmin
GRMN
$46.4B
$1.7M 1.24%
6,898
+54
+0.8% +$12.5K
BMY icon
27
Bristol-Myers Squibb
BMY
$128B
$1.68M 1.23%
37,300
– –
SRE icon
28
Sempra
SRE
$60.1B
$1.67M 1.22%
18,600
– –
GOOGL icon
29
Alphabet (Google) Class A
GOOGL
$4.01T
$1.48M 1.08%
6,100
– –
ET icon
30
Energy Transfer Partners
ET
$68.8B
$1.38M 1.01%
80,640
– –
WEC icon
31
WEC Energy
WEC
$37.3B
$1.34M 0.98%
11,706
– –
XOM icon
32
ExxonMobil
XOM
$642B
$1.26M 0.92%
11,200
– –
MA icon
33
Mastercard
MA
$489B
$1.26M 0.92%
2,216
+202
+10% +$116K
XEL icon
34
Xcel Energy
XEL
$50.5B
$1.25M 0.91%
15,500
– –
LHX icon
35
L3Harris
LHX
$56.6B
$1.24M 0.9%
4,044
– –
DIS icon
36
Walt Disney
DIS
$168B
$1.15M 0.84%
10,000
– –
HON icon
37
Honeywell
HON
$77B
$1.14M 0.83%
5,729
– –
MCD icon
38
McDonald's
MCD
$192B
$1.12M 0.82%
3,700
– –
COP icon
39
ConocoPhillips
COP
$143B
$1.03M 0.75%
10,900
– –
MCO icon
40
Moody's
MCO
$84.3B
$953K 0.7%
2,000
– –
BLD
41
DELISTED
TopBuild
BLD
$882K 0.65%
2,257
+46
+2% +$18.4K
RACE icon
42
Ferrari
RACE
$66.3B
$877K 0.64%
1,808
+28
+2% +$13.4K
AAPL icon
43
Apple
AAPL
$4.95T
$850K 0.62%
3,338
– –
IDR icon
44
Idaho Strategic Resources
IDR
$449M
$835K 0.61%
24,715
-26,800
-52% -$633K
LNKB
45
DELISTED
LINKBANCORP
LNKB
$820K 0.6%
114,917
-2,100
-2% -$15.2K
ULTA icon
46
Ulta Beauty
ULTA
$20.6B
$820K 0.6%
1,499
+24
+2% +$12.3K
KO icon
47
Coca-Cola
KO
$360B
$811K 0.59%
12,230
– –
MEDP icon
48
Medpace
MEDP
$16.5B
$795K 0.58%
1,546
+64
+4% +$27.9K
TROW icon
49
T. Rowe Price
TROW
$25.3B
$785K 0.57%
7,650
– –
PPL
50
PPL Corp
PPL
$27.1B
$776K 0.57%
20,880
– –
1
2
3 4

Similar funds

UOP
University of Pittsburgh Pittsburgh, Pennsylvania $135M AUM 29.36% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
ICM
Isabella Capital Management London $135M AUM
GEH
General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return
AV
Alamea Verwaltungs Edison, New Jersey $135M AUM 36.32% 1-Year Est. Return
SA
Seneschal Advisors Tacoma, Washington $135M AUM 13.18% 1-Year Est. Return
JAA
Joel Adams & Associates Asheville, North Carolina $135M AUM 10.83% 1-Year Est. Return
SG
Somerset Group Wayzata, Minnesota $135M AUM 21.18% 1-Year Est. Return

Enhancing Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Enhancing Capital held 94 positions worth $137M, up 4.2% from $131M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Enhancing Capital's Q3 2025 filing shows 2 new, 20 increased, 7 reduced and 7 closed positions. Its largest new stake was Preformed Line Products: 1,860 shares worth $365K. The largest sale was Pfizer, an estimated $1.01M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Utilities.

  • Enhancing Capital's largest Q3 2025 buy was Preformed Line Products: 1,860 shares worth $365K.
  • Enhancing Capital added most to NVIDIA in Q3 2025, an estimated $697K increase.
  • Enhancing Capital's biggest Q3 2025 reduction was Idaho Strategic Resources, cutting an estimated $633K.
  • Enhancing Capital fully exited Pfizer in Q3 2025, selling an estimated $1.01M.
  • Enhancing Capital's ten largest holdings make up 42% of its $137M portfolio in Q3 2025.
  • Enhancing Capital opened 2 new positions and closed 7 in Q3 2025.
  • Enhancing Capital's portfolio value rose 4.2% quarter-over-quarter to $137M.

Based on Enhancing Capital's 13F filing for Q3 2025, filed 13 Nov 2025.